Commercialization building with large pharma contracts secured Further progress on next generation sequencing assays for DNA ...

A study published in ACS Nano presents a novel biosensor for the isothermal, highly sensitive detection of bladder cancer ...

During a live event, Deborah Wong, MD, PhD, discussed the role of EBV and challenges in nasopharyngeal cancer diagnosis with ...

A highly sensitive real-time PCR-based systems helps scientists rapidly detect microbial contamination in cell therapy ...

Researchers found that flight attendants show reduced DNA repair capacity and immune changes after air travel, which may help ...

Collectively, the data presented here suggest that the PhasED-Seq-based MRD assay is accurate and reproducible, making it appropriate for use in the ...

A single assay provides real-time, intraoperative methylome classification of CNS tumours with complete diagnosis available ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that data from more ...

A successful CRISPR knockin isn’t just about inserting DNA. It’s about ensuring that edit stays functional and reliable over ...

Head and neck cancer researchers are reporting the development and testing of HPV-DeepSeek, a novel liquid biopsy assay. In their new study, HPV-DeepSeek achieved 99% sensitivty and specifity for ...

DeepSeek, a liquid biopsy blood test achieving 99% sensitivity for early detection of HPV-associated head and neck cancers.

Researchers tested the performance of the whole-genome sequencing-based assay head-to-head against ctDNA and ddPCR assays.